Trial Profile
Dapagliflozin Lowers Plasma Glucose Concentration and Improves Beta Cell Function.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Nov 2015 Status changed from not stated to completed.
- 03 Nov 2015 New trial record